{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T00:05:45Z","timestamp":1773533145327,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.yjmcc.2023.03.007","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T21:35:13Z","timestamp":1679520913000},"page":"36-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["RyR2-targeting therapy prevents left ventricular remodeling and ventricular tachycardia in post-infarction heart failure"],"prefix":"10.1016","volume":"178","author":[{"given":"Shohei","family":"Fujii","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaowei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junya","family":"Nawata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Yoshitomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiaki","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihide","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Ishiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Suetomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Uchinoumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2023.03.007_bb0005","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1161\/01.CIR.0000070420.51787.A8","article-title":"Left ventricular remodeling and ventricular arrhythmias after myocardial infarction","volume":"107","author":"St John Sutton","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2023.03.007_bb0010","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jcmg.2008.05.012","article-title":"Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (valsartan in acute myocardial infarction) echocardiographic study","volume":"1","author":"Verma","year":"2008","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.yjmcc.2023.03.007_bb0015","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41569-020-0394-8","article-title":"Intracellular calcium leak: a unifying mechanism and therapeutic target for heart failure and atrial fibrillation","volume":"17","author":"Dridi","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.yjmcc.2023.03.007_bb0020","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/ehf2.12271","article-title":"Human cardiomyocyte calcium handling and transverse tubules in mid-stage of post-myocardial-infarction heart failure","volume":"5","author":"H\u00f8ydal","year":"2018","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.yjmcc.2023.03.007_bb0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.yjmcc.2016.06.007","article-title":"CaMKII-dependent phosphorylation of RyR2 promotes targetable pathological RyR2 conformational shift","volume":"98","author":"Uchinoumi","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2023.03.007_bb0030","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3389\/fphys.2020.01068","article-title":"Targeting Ca2+ handling protein S for the treatment of heart failure and arrhythmias","volume":"11","author":"Njegic","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.yjmcc.2023.03.007_bb0035","doi-asserted-by":"crossref","first-page":"d671","DOI":"10.2741\/ikemoto","article-title":"Regulation of calcium release by interdomain interaction within ryanodine receptors","volume":"7","author":"Ikemoto","year":"2002","journal-title":"Front. Biosci."},{"key":"10.1016\/j.yjmcc.2023.03.007_bb0040","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/ncpcardio0419","article-title":"Mechanisms of disease: ryanodine receptor defects in heart failure and fatal arrhythmia","volume":"3","author":"Yano","year":"2006","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.yjmcc.2023.03.007_bb0045","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1161\/CIRCULATIONAHA.104.507921","article-title":"Defective regulation of interdomain interactions within the ryanodine receptor plays a key role in the pathogenesis of heart failure","volume":"111","author":"Oda","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2023.03.007_bb0050","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1161\/CIRCULATIONAHA.105.555623","article-title":"Correction of defective inter-domain interaction within ryanodine receptor by antioxidant is a new therapeutic strategy against heart failure","volume":"112","author":"Yano","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2023.03.007_bb0055","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1161\/CIRCULATIONAHA.107.718957","article-title":"Identification of target domains of the cardiac ryanodine receptor to correct channel disorder in failing hearts","volume":"117","author":"Yamamoto","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2023.03.007_bb0060","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1161\/CIRCRESAHA.109.209312","article-title":"Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor","volume":"106","author":"Uchinoumi","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2023.03.007_bb0065","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1253\/circj.CJ-10-0680","article-title":"Dantrolene, a therapeutic agent for malignant hyperthermia, inhibits catecholaminergic polymorphic ventricular tachycardia in a RyR2R2474S\/+ knockin mouse model","volume":"74","author":"Kobayashi","year":"2010","journal-title":"Circ. J."},{"key":"10.1016\/j.yjmcc.2023.03.007_bb0070","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.bbrc.2010.03.046","article-title":"Defective calmodulin binding to the cardiac ryanodine receptor plays a key role in CPVT-associated channel dysfunction","volume":"394","author":"Xu","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yjmcc.2023.03.007_bb0075","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/cvr\/cvq108","article-title":"Dissociation of calmodulin from cardiac ryanodine receptor causes aberrant Ca2+ release in heart failure","volume":"87","author":"Ono","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2023.03.007_bb0080","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/cvr\/cvs271","article-title":"Enhanced binding of calmodulin to the ryanodine receptor corrects contractile dysfunction in failing hearts","volume":"96","author":"Hino","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2023.03.007_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2014.03.152","article-title":"Enhanced binding of calmodulin to RyR2 corrects arrhythmogenic channel disorder in CPVT-associated myocytes","volume":"448","author":"Fukuda","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yjmcc.2023.03.007_bb0090","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.hrthm.2016.10.019","article-title":"Correction of impaired calmodulin binding to RyR2 as a novel therapy for lethal arrhythmia in the pressure-overloaded heart failure","volume":"14","author":"Kato","year":"2017","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.yjmcc.2023.03.007_bb0095","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bbrc.2019.10.071","article-title":"Dantrolene prevents ventricular tachycardia by","volume":"521","author":"Kajii","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yjmcc.2023.03.007_bb0100","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.126112","article-title":"Ryanodine receptor-bound calmodulin is essential to protect against catecholaminergic polymorphic ventricular tachycardia","volume":"4","author":"Nakamura","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.yjmcc.2023.03.007_bb0105","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/s42003-020-01443-w","article-title":"Enhancing calmodulin binding to cardiac ryanodine receptor completely inhibits pressure-overload induced hypertrophic signaling","volume":"3","author":"Kohno","year":"2020","journal-title":"Commun Biol"},{"key":"10.1016\/j.yjmcc.2023.03.007_bb0110","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41586-019-1377-y","article-title":"Modulation of cardiac ryanodine receptor 2 by calmodulin","volume":"572","author":"Gong","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2023.03.007_bb0115","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1152\/physrev.1996.76.2.537","article-title":"Malignant hyperthermia: excitation-contraction coupling, Ca2+ release channel, and cell Ca2+ regulation defects","volume":"76","author":"Mickelson","year":"1996","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.yjmcc.2023.03.007_bb0120","doi-asserted-by":"crossref","first-page":"34918","DOI":"10.1074\/jbc.M205487200","article-title":"Identification of a dantrolene-binding sequence on the skeletal muscle ryanodine receptor","volume":"277","author":"Paul-Pletzer","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2023.03.007_bb0125","doi-asserted-by":"crossref","first-page":"6580","DOI":"10.1074\/jbc.M408375200","article-title":"Dantrolene stabilizes domain interactions within the ryanodine receptor","volume":"280","author":"Kobayashi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2023.03.007_bb0130","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1042\/BJ20041336","article-title":"Probing a putative dantrolene-binding site on the cardiac ryanodine receptor","volume":"387","author":"Paul-Pletzer","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.yjmcc.2023.03.007_bb0135","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.jacc.2009.01.065","article-title":"Dantrolene, a therapeutic agent for malignant hyperthermia, markedly improves the function of failing cardiomyocytes by stabilizing interdomain interactions within the ryanodine receptor","volume":"53","author":"Kobayashi","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2023.03.007_bb0140","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1161\/01.CIR.0000165066.71481.8E","article-title":"Postinfarction gene therapy against transforming growth factor-\u03b2 signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure","volume":"111","author":"Okada","year":"2005","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.yjmcc.2023.03.007_bb0145","first-page":"2230","article-title":"Leaky Ca2+ release channel\/ryanodine receptor 2 causes seizures and sudden cardiac death in mice","volume":"118","author":"Lehnart","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.yjmcc.2023.03.007_bb0150","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1073\/pnas.0908540107","article-title":"Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy","volume":"107","author":"Fauconnier","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yjmcc.2023.03.007_bb0155","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1161\/CIRCRESAHA.111.300290","article-title":"In cardiomyocytes, binding of unzipping peptide activates ryanodine receptor 2 and reciprocally inhibits calmodulin binding","volume":"112","author":"Oda","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2023.03.007_bb0160","doi-asserted-by":"crossref","first-page":"aah5324","DOI":"10.1126\/science.aah5324","article-title":"Structural basis for the gating mechanism of the type 2 ryanodine receptor RyR2","volume":"354","author":"Peng","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.yjmcc.2023.03.007_bb0165","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bbrc.2022.12.063","article-title":"Stabilizing cardiac ryanodine receptor with dantrolene treatment prevents left ventricular remodeling in pressure-overloaded heart failure mice","volume":"642","author":"Yano","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yjmcc.2023.03.007_bb0170","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.122.011220","article-title":"Stabilizing tetrameric structure of ryanodine receptor cures lethal arrhythmia in heart failure","volume":"15","author":"Kobayashi","year":"2022","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"10.1016\/j.yjmcc.2023.03.007_bb0175","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jjcc.2019.08.020","article-title":"A multicenter, randomized, double-blind, controlled study to evaluate the efficacy and safety of dantrolene on ventricular arrhythmia as well as mortality and morbidity in patients with chronic heart failure (SHO-IN trial): rationale and design","volume":"75","author":"Kobayashi","year":"2020","journal-title":"J. Cardiol."},{"issue":"2","key":"10.1016\/j.yjmcc.2023.03.007_bb0180","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1161\/CIRCRESAHA.114.302857","article-title":"Cardiac myocyte Z-line calmodulin is mainly RyR2-bound, and reduction is arrhythmogenic and occurs in heart failure","volume":"114","author":"Yang","year":"2014","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.yjmcc.2023.03.007_bb0185","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ceca.2006.07.011","article-title":"Free and bound intracellular calmodulin measurements in cardiac myocytes","volume":"41","author":"Wu","year":"2007","journal-title":"Cell Calcium"}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282823000524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282823000524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T20:37:54Z","timestamp":1758314274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282823000524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":37,"alternative-id":["S0022282823000524"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2023.03.007","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RyR2-targeting therapy prevents left ventricular remodeling and ventricular tachycardia in post-infarction heart failure","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2023.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}